Bioxcel Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsBioxcel Therapeutics

Bioxcel Therapeutics(BTAI)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Igalmi	Dexmedetomidine	2022-04-05	2032-2039	Pain , Premedication , Psychomotor agitation , Conscious sedation

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Dexmedetomidine

conscious sedation

drug-related side effects and adverse reactions

,

healthy volunteers/patients

,

sleep initiation and maintenance disorders

,

,

lennox gastaut syndrome

,

,

treatment-resistant schizophrenia

,

myoclonic epilepsies

,

,

generalized epilepsy

,

epilepsia partialis continua

,

psychotic disorders

,

schizophrenia spectrum and other psychotic disorders

,

,

partial epilepsies

,

drug resistant epilepsy

,

status epilepticus

renal insufficiency

,

,

t-cell lymphoma

,

immunoblastic lymphadenopathy

,

enteropathy-associated t-cell lymphoma

,

t-cell lymphoma peripheral

,

,

neuroendocrine tumors

,

carcinoid tumor

,

malignant carcinoid syndrome

,

carcinoid heart disease

,

serotonin syndrome

second primary neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

head and neck neoplasms

,

small cell lung carcinoma

,

non-small-cell lung carcinoma

,

stomach neoplasms

,

liver neoplasms

,

hepatocellular carcinoma

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

colorectal neoplasms

,

,

,

,

,

renal cell carcinoma

,

,

urologic neoplasms

,

transitional cell carcinoma

,

biliary tract neoplasms

,

,

hodgkin disease

,

esophageal neoplasms

,

esophageal squamous cell carcinoma

,

cholangiocarcinoma

,

pancreatic ductal carcinoma

,

pancreatic neoplasms

,

,

ovarian neoplasms

,

tertiary lymphoid structures

,

non-hodgkin lymphoma

,

large-cell lymphoma anaplastic

,

t-cell lymphoma peripheral

,

brain neoplasms

,

triple negative breast neoplasms

,

merkel cell carcinoma

,

neoplasm metastasis

,

breast neoplasms

,

,

endometrial neoplasms

,

uterine neoplasms

Aglatimagene besadenovec

,

,

triple negative breast neoplasms

,

,

pharmacokinetics

,

healthy volunteers/patients

,

pharmacological phenomena

,

breast neoplasms

,

,

,

ovarian neoplasms

,

pancreatic neoplasms

,

non-small-cell lung carcinoma

,

colorectal neoplasms

,

uterine cervical neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

urinary bladder neoplasms

,

small cell lung carcinoma

,

biliary tract neoplasms

,

,

,

hereditary sensory and autonomic neuropathies

,

hereditary breast and ovarian cancer syndrome

,

,

fallopian tube neoplasms

,

,

head and neck neoplasms

,

dna repair-deficiency disorders

,

,

x-linked bulbo-spinal atrophy

,

neoplasm metastasis

,

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

,

atopic dermatitis

,

atherosclerosis

Globulin, immune

hereditary sensory and autonomic neuropathies

,

pancreatic neoplasms

renal cell carcinoma

,

,

non-small-cell lung carcinoma

,

urinary bladder neoplasms

,

,

,

alcohol drinking

,

post-traumatic stress disorders

,

opioid-related disorders

,

morphine dependence

,

,

traumatic stress disorders acute

,

,

psychomotor agitation

,

,

psychotic disorders

,

bipolar disorder

,

psychotic affective disorders

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use